Eagle Health Investments LP Portfolio
Auto-discovered 13F filer (Top-2000 by latest reported value).
SEC 13F CIK: 0001842545
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Q4 2024 · 18 positions · Total reported value $407.92M · Top-10 concentration 85.0% · Updated 2026-10-18
Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR
Turnover: 54.8% · 4 new · 4 cut · 9 exited
Active Share (vs S&P 500): 99.7% · vs QQQ: 99.4% — share of the book that differs from index weights (higher = more active) · ranking
In its Q4 2024 13F filing, Eagle Health Investments LP disclosed 18 equity positions with a combined reported value of $407.92M. The filing implies a focused portfolio: its ten largest positions account for 85.0% of reported value. HoldingsHub classifies the profile as Small / Focused / Health Tilt / High Turnover.
The largest disclosed positions as of Q4 2024 were NTRA ($53.78M), ARGX ($46.12M), ILMN ($45.88M). By sector, the heaviest allocations are Health Care 100.0%. Versus the prior quarter, allocation shifted toward Health Care (+7.0pp) and away from Other (-7.0pp).
Versus the prior quarter, Eagle Health Investments LP opened 4 new positions, trimmed 4 and fully exited 9, a turnover rate of 54.8% of positions. The portfolio's overlap with the prior quarter was 72% of names.
Of the 9 positions fully exited versus the prior quarter, the largest were EXAS ($37.07M), UNH ($29.64M), CRSP ($9.26M).
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
New Positions (Q4 2024)
No new positions this quarter.
Fully Exited (vs previous quarter)
- EXAS EXACT SCIENCES CORP · prev qtr: $37.07M
- UNH UNITEDHEALTH GROUP INC · prev qtr: $29.64M
- CRSP CRISPR THERAPEUTICS AG · prev qtr: $9.26M
- FDMT 4D MOLECULAR THERAPEUTICS IN · prev qtr: $5.00M
- LNTH LANTHEUS HLDGS INC · prev qtr: $4.74M
- VKTX VIKING THERAPEUTICS INC · prev qtr: $2.85M
- HOWL WEREWOLF THERAPEUTICS INC · prev qtr: $1.48M
Insider Transactions (Form 4)
Latest Eagle Health Investments LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.
Fund Profile
Eagle Health Investments LP, based in Greenwich, CT, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 27 positions worth $603.31M in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).
Firm Snapshot
- Headquarters: GREENWICH, CT, United States
- SEC registration: 801-121917 (status: Approved), registered 2021-07-29
- Regulatory AUM (Form ADV): $605.26M as of 2026-03-28
- Client mix (by RAUM): pension and profit-sharing plans 100%
- Manages 1 private funds, of which 1 hedge funds
Portfolio Structure
- 27 positions · $603.31M reported value (Q2 2026)
- Top 10 holdings = 66.1% of reported value
- Largest position: ARGX (ARGENX SE FUNSPONSORED ADR 1 ADR REPS 1 ORD SHS) at 11.8%
- Average position size: $22.34M
Sector Tilt
- Health Care 96.0%
- Information Technology 2.5%
- (classified holdings cover 98% of value)
Quarterly Activity
- Q2 2026: 5 new, 9 added, 4 reduced, 5 exited
- 9 positions unchanged
Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.
Sector Allocation
| # | Company | Shares | Value | Weight | Allocation | Change |
|---|---|---|---|---|---|---|
| 1 |
|
339.76K | $53.78M | 13.19% | Reduce | |
| 2 |
|
74.99K | $46.12M | 11.31% | Hold | |
| 3 |
|
343.36K | $45.88M | 11.25% | Reduce | |
| 4 |
|
209.19K | $43.87M | 10.75% | Add | |
| 5 |
|
513.70K | $35.47M | 8.69% | Hold | |
| 6 |
|
419.21K | $27.55M | 6.75% | Hold | |
| 7 |
|
627.60K | $26.40M | 6.47% | Add | |
| 8 |
|
136.60K | $25.32M | 6.21% | Hold | |
| 9 |
|
274.55K | $21.35M | 5.23% | Reduce | |
| 10 |
|
155.00K | $21.16M | 5.19% | Add | |
| 11 |
|
233.09K | $18.77M | 4.60% | Hold | |
| 12 |
|
76.26K | $17.94M | 4.40% | Hold | |
| 13 |
|
330.83K | $10.87M | 2.67% | Hold | |
| 14 |
|
21.80K | $7.69M | 1.89% | Reduce | |
| 15 |
|
4.39K | $2.29M | 0.56% | Reduce | |
| 16 |
|
46.30K | $1.37M | 0.34% | Hold | |
| 17 |
|
18.06K | $1.13M | 0.28% | Hold | |
| 18 |
|
53.12K | $948.26K | 0.23% | Hold | |
FAQ
What did Eagle Health Investments LP buy in 2024-Q4?
In its 2024-Q4 13F filing, Eagle Health Investments LP reported 18 equity positions worth $407.92M in aggregate; its largest disclosed positions were NTRA ($53.78M), ARGX ($46.12M), ILMN ($45.88M).
How large is Eagle Health Investments LP's portfolio?
Eagle Health Investments LP reported $407.92M of long equity holdings across 18 positions as of 2024-Q4. Top-10 holdings account for 85.0% of reported value.
What is Eagle Health Investments LP's investment style?
HoldingsHub classifies the portfolio as Small / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.